TMO

Thermo Fisher Scientific Inc

NYSEUSDEQUITY DELAYED

628.50

▲ 0.95 (0.15%)

MARKET · —

Price

Open

634.00

Prev close

627.55

Day high

629.49

Day low

616.27

Volume

1.56M

Market cap

—

P/E (TTM)

—

52W range

435.27 – 643.99

Trailing performance

Price return · vs SPY

Returnvs SPY

+6.97% +8.3%

+9.95% +6.2%

+40.03% +36.9%

+23.16% +12.1%

YTD

+8.60% -3.7%

+27.17% +7.2%

+18.98% -55.2%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

603.68

+4.11% from price

SMA 20

589.54

+6.74% from price

SMA 50

541.68

+16.17% from price

SMA 100

510.69

+23.07% from price

SMA 200

533.80

+17.88% from price

EMA 12

601.19

+4.54% from price

EMA 26

580.23

+8.32% from price

EMA 50

554.50

+13.34% from price

RSI (14)

74.6

Overbought

MACD (12,26,9)

20.95

Hist 1.40

ATR (14)

14.97

2.38% of price

Realised vol 30D

31.9%

Annualised

Bollinger upper

626.76

20, 2σ

Bollinger lower

552.33

20, 2σ

50 / 200 cross

Golden

541.68 vs 533.80

Trend bias

Above 200

+17.88%

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.60

Less volatile than market

Correlation to SPY

0.25

Largely independent

Realised vol 30D

31.9%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-31.5%

Peak to trough

Max drawdown 5Y

-41.5%

Peak to trough

ATR 14

14.97

2.38% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 628.50

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

TMO · links out to the publisher

Agilent Stock Has A Catalyst Coming On August 26 That Investors Should Not Ignore 24/7 Wall St. · 19h ago XPO names chief legal officer Trucking Dive · 23h ago William O'Neil Initiates Thermo Fisher Scientific at Buy MT Newswires · 24h ago Thermo Fisher Scientific Insider Sold Shares Worth $7,014,093, According to a Recent SEC Filing MT Newswires · 2d ago Bio-Rad Gains 19.1% in the Past Month: Can Its Momentum Keep Building? Zacks · 2d ago Protein Design & Engineering Market Global Report 2026: Evaluating AI Platforms, Rational Design, Directed Evolution, and Strategies of Lonza, Thermo Fisher, GenScript, and Charles River GlobeNewswire · 3d ago Here's How Abbott's Medical Devices Arm Acts as a Growth Catalyst Zacks · 3d ago Q2 Earnings Highs And Lows: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks StockStory · 3d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.